ENTITY

Fangzhou (6086 HK)

4
Analysis
Information TechnologyHong Kong
Fangzhou Inc. operates as an online chronic disease management platform. The Company provides chronic disease management. Fangzhou provides its services in China.
more
bearishFangzhou
17 Jun 2024 08:55

Pre-IPO Fangzhou Inc. (PHIP Updates) - Some Points Worth the Attention

​Fangzhou faces challenges with decreasing drug price due to VBP/NRDL negotiation. The internal disputes, litigation, cash flow pressure will lead...

Logo
187 Views
Share
17 Dec 2024 05:10

HSCI Index Rebalance Preview and Stock Connect: Potential Changes in March 2025

There could be 78 changes for the HSCI in March. That could result in 57 changes to the Southbound Stock Connect list and also have implications...

Logo
500 Views
Share
20 Nov 2024 13:57

Quiddity Leaderboard Hang Seng Biotech Dec 24: Positive Flows for Beigene and Innovent Biologics

QuantumPharm (2228 HK) and Fangzhou (6086 HK) are expected ADDs. 3D Medicines (1244 HK) and CARSgen Therapeutics (2171 HK) are expected DELs.

Share
bullishQuantumPharm
13 Oct 2024 06:05

Quiddity Leaderboard Hang Seng Biotech Dec 24: Two Changes Expected + Capping Flows

Assuming the two index changes expected in this insight take place, there will be US$33mn capping flow which translates to a turnover of 2.8%. Five...

Share
No more insights
x